Literature DB >> 19157856

Prion protein misfolding and disease.

Roger A Moore1, Lara M Taubner, Suzette A Priola.   

Abstract

Transmissible spongiform encephalopathies (TSEs or prion diseases) are a rare group of invariably fatal neurodegenerative disorders that affect humans and other mammals. TSEs are protein misfolding diseases that involve the accumulation of an abnormally aggregated form of the normal host prion protein (PrP). They are unique among protein misfolding disorders in that they are transmissible and have different strains of infectious agents that are associated with unique phenotypes in vivo. A wealth of biological and biophysical evidence now suggests that the molecular basis for prion diseases may be encoded by protein conformation. The purpose of this review is to provide an overview of the existing structural information for PrP within the context of what is known about the biology of prion disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19157856      PMCID: PMC2674794          DOI: 10.1016/j.sbi.2008.12.007

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  72 in total

Review 1.  Three-dimensional structures of prion proteins.

Authors:  K Wüthrich; R Riek
Journal:  Adv Protein Chem       Date:  2001

2.  Crystal structure of the human prion protein reveals a mechanism for oligomerization.

Authors:  K J Knaus; M Morillas; W Swietnicki; M Malone; W K Surewicz; V C Yee
Journal:  Nat Struct Biol       Date:  2001-09

3.  N-terminal truncation of prion protein affects both formation and conformation of abnormal protease-resistant prion protein generated in vitro.

Authors:  V A Lawson; S A Priola; K Wehrly; B Chesebro
Journal:  J Biol Chem       Date:  2001-07-20       Impact factor: 5.157

4.  Structural studies of the scrapie prion protein by electron crystallography.

Authors:  Holger Wille; Melissa D Michelitsch; Vincent Guenebaut; Surachai Supattapone; Ana Serban; Fred E Cohen; David A Agard; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

5.  Efficient conversion of normal prion protein (PrP) by abnormal hamster PrP is determined by homology at amino acid residue 155.

Authors:  S A Priola; J Chabry; K Chan
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

6.  Susceptibility of sheep for scrapie as assessed by in vitro conversion of nine naturally occurring variants of PrP.

Authors:  A Bossers; R de Vries; M A Smits
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

7.  NMR solution structure of the human prion protein.

Authors:  R Zahn; A Liu; T Lührs; R Riek; C von Schroetter; F López García; M Billeter; L Calzolai; G Wider; K Wüthrich
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

8.  NMR structure of the bovine prion protein.

Authors:  F López Garcia; R Zahn; R Riek; K Wüthrich
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

9.  Deletion of beta-strand and alpha-helix secondary structure in normal prion protein inhibits formation of its protease-resistant isoform.

Authors:  I Vorberg; K Chan; S A Priola
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  Multiple amino acid residues within the rabbit prion protein inhibit formation of its abnormal isoform.

Authors:  Ina Vorberg; Martin H Groschup; Eberhard Pfaff; Suzette A Priola
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more
  31 in total

1.  Interactions between the conserved hydrophobic region of the prion protein and dodecylphosphocholine micelles.

Authors:  Simon Sauvé; Daniel Buijs; Geneviève Gingras; Yves Aubin
Journal:  J Biol Chem       Date:  2011-11-29       Impact factor: 5.157

2.  Dissociation of recombinant prion protein fibrils into short protofilaments: implications for the endocytic pathway and involvement of the N-terminal domain.

Authors:  Xu Qi; Roger A Moore; Michele A McGuirl
Journal:  Biochemistry       Date:  2012-05-23       Impact factor: 3.162

Review 3.  Chaperoning osteogenesis: new protein-folding disease paradigms.

Authors:  Elena Makareeva; Nydea A Aviles; Sergey Leikin
Journal:  Trends Cell Biol       Date:  2010-12-21       Impact factor: 20.808

4.  Identification and removal of proteins that co-purify with infectious prion protein improves the analysis of its secondary structure.

Authors:  Roger A Moore; Andrew G Timmes; Phillip A Wilmarth; David Safronetz; Suzette A Priola
Journal:  Proteomics       Date:  2011-09-07       Impact factor: 3.984

5.  Do prion protein gene polymorphisms induce apoptosis in non-mammals?

Authors:  Tuğçe Birkan; Mesut Şahin; Zubeyde Öztel; Erdal Balcan
Journal:  J Biosci       Date:  2016-03       Impact factor: 1.826

Review 6.  Expectations, validity, and reality in gene expression profiling.

Authors:  Kyoungmi Kim; Stanislav O Zakharkin; David B Allison
Journal:  J Clin Epidemiol       Date:  2010-06-25       Impact factor: 6.437

Review 7.  Recent advances in our understanding of neurodegeneration.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2009-06-05       Impact factor: 3.575

Review 8.  Minocycline as a potential therapeutic agent in neurodegenerative disorders characterised by protein misfolding.

Authors:  Wendy Noble; Claire J Garwood; Diane P Hanger
Journal:  Prion       Date:  2009-04-21       Impact factor: 3.931

9.  Human prion diseases in the United States.

Authors:  Robert C Holman; Ermias D Belay; Krista Y Christensen; Ryan A Maddox; Arialdi M Minino; Arianne M Folkema; Dana L Haberling; Teresa A Hammett; Kenneth D Kochanek; James J Sejvar; Lawrence B Schonberger
Journal:  PLoS One       Date:  2010-01-01       Impact factor: 3.240

10.  RNA-silencing enzymes Pol IV and Pol V in maize: more than one flavor?

Authors:  Craig S Pikaard; Sarah Tucker
Journal:  PLoS Genet       Date:  2009-11-20       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.